Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow References
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Delta Bella, P.
Right arrow Articles by Tondo, C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Delta Bella, P.
Right arrow Articles by Tondo, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Stratification and outcomes in patients with paroxysmal atrial fibrillation: pulmonary vein ablation versus linear lesions

P. Delta Bella* and C. Tondo

Institute of Cardiology, University of Milan, Centro Cardiologico, Fondazione Monzino, IRCCS, Milan, Italy

* Correspondence: Paolo Della Bella, MD, Institute of Cardiology, University of Milan, Centro Cardiologico, Fond. Monzino, IRCCS, Via Parea, 4, 20138 Milan, Italy.

Abstract

Introduction and method Because of the heterogeneity of atrial fibrillation (AF), various ablative approaches have been proposed in order to identify an effective treatment for the arrhythmias. The aim of the present study was to report the long-term clinical outcome of patients undergoing two distinct ablative strategies: right linear lesions and pulmonary vein ablation. Based on mapping, group 1 (n = 58) included patients who underwent focal ablation or an attempt at pulmonary vein isolation, whereas group 2 (n = 40) included patients selected for right linear lesions.

Results In group 1, over a mean follow up of 12 ± 2 months, 39 patients (67%) were in stable sinus rhythm, and 18 (46%) were off drug treatment. An additional 11 patients (19%) had sporadic AF episodes on drug therapy. An unchanged clinical scenario was reported in eight patients (14%). In group 2, at a mean follow up of 19 ± 4 months, 23 patients (57%) were in regular sinus rhythm and 12 patients (30%) were off drug treatment. Recurrences occurred in 17 patients (42%), but the number of symptomatic AF episodes decreased from 4 ± 2 per month to 0.9 ± 0.3 per month ().

Conclusion Right linear ablation can improve the quality of life in patients with AF, but it offers a lower success rate in terms of long-term outcome in comparison with pulmonary vein ablation. The results support the concept that the atrial muscle extending into the pulmonary vein plays a critical role in the pathophysiology of AF.

Key Words: Atrial fibrillation • atrial mapping • radiofrequency linear ablation • radiofrequency pulmonary vein ablation • antiarrhythmic drugs


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.